156 results
425
BMY
Bristol-Myers Squibb Co.
31 Jan 19
Business combination disclosure
12:00am
– A Legacy of Innovation William McLaren Bristol1860-1935 Clinton Pharmaceuticals founded in 1887 Squibb Laboratories founded in 1858 Bristol-Myers Squibb … performanceenergizing work experienceuncompromising ethics OUR Our Vision Accountability Innovation Passion Speed
Bristol-Myers Squibb at a Glance BMY
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
, industry-leading science and a culture of collaboration and innovation. Together, we will create the leading biopharma company, one that will be known … & Development
The new structure will focus on the innovation core to both companies’ success, pairing internal discovery with strong partnerships
SC TO-C
EX-99.7
MYOK
MyoKardia, Inc.
5 Oct 20
Information about tender offer
5:13pm
-stage therapeutics: danicamtiv (formerly MYK-491) and MYK-224.
Our companies share a commitment to innovation and bold science, as well as a strong … of seeking external innovation to complement our internal capabilities.
We are further strengthening and accelerating the expansion of our outstanding
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
11 Jan 21
Regulation FD Disclosure
7:16am
innovation Disciplined business development Early pipeline strengthened & CV franchise renewal accelerated with MyoKardia Zeposia UC deucravacitinib PsO … innovation Diverse internal pipeline with20 assets with proof of concept decisions over next 2-3 yearsStrong R&D capabilitiesSignificant capital
425
BMY
Bristol-Myers Squibb Co.
3 Jan 19
Business combination disclosure
5:17pm
, immunology and inflammation, cardiovascular disease and fibrotic disease, leveraging our combined strengths in innovation.
Integrate a broad range … of discovery modalities that will further strengthen our pipeline. The new company will be a leader in science and innovation, with expanded innovation
8-K
EX-99.1
8zdt73bl ig
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-99.3
q4dw9 cwz
3 Jan 19
Regulation FD Disclosure
7:58am
SC TO-C
EX-99.4
xza328ldb2u0blejfea1
26 Dec 23
Information about tender offer
4:22pm
425
o5ng1 2xrqb16ak
3 Jan 19
Business combination disclosure
5:26pm
425
1nitypa
19 Nov 09
Business combination disclosure
12:00am
425
6worh weai6wttip6y
7 Jan 19
Business combination disclosure
5:27pm
425
EX-99.3
2bzxlq7wvnb
3 Jan 19
Business combination disclosure
7:56am
8-K
EX-99.1
w21nb
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
8-K
EX-99.2
rtegr2a
3 Jan 19
Regulation FD Disclosure
7:58am
8-K
EX-99.3
nqodvr rdsdk
24 Jan 19
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
8:54am
425
EX-99.2
wjt30aj2
3 Jan 19
Business combination disclosure
7:56am
SC TO-C
EX-99.6
ool9gzw3hm bqhvk6
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.5
undw 3ym5
26 Dec 23
Information about tender offer
4:22pm
425
5pznlhw9z7e3dif9doyg
22 Feb 19
Business combination disclosure
4:53pm
425
97jjwhddmp9cq6 iv61l
20 Feb 19
Business combination disclosure
9:29am